Pharmaceutical and Biotech Companies
Challenge: Medication Adherence has never been more important
Fewer new products are in the market, and there is a growing emphasis on targeted therapies across smaller markets.
The cost of most adherence programs (e.g., letters, calls, provider outreach) are per contact, with multiple contacts per patient:
- Low-cost, high-scale programs are of limited effectiveness
- More intensive, “high-touch” interventions are difficult to scale
The RxAnte Solution’s customized evidenced-based decision support capabilities can help manufacturers and pharmacies implement more effective interventions that could not previously be justified at scale, achieving greater overall program effectiveness and ROI.